The renin-angiotensin system and reactive oxygen species: Implications in pancreatitis

Antioxidants and Redox Signaling

Volumn 15, Issue 10, 2011, Pages 2743-2755

  Chan, Yuk Cheung ^a   Leung, Po Sing ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ACUTE PANCREATITIS; BLOOD PRESSURE REGULATION; CHRONIC PANCREATITIS; ELECTROLYTE BALANCE; EPIGENETICS; GENE EXPRESSION; GENETIC DISORDER; HUMAN; NONHUMAN; PANCREATITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ACUTE DISEASE; CHRONIC DISEASE; HUMANS; PANCREATITIS; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM;

EID: 80054011428     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4071     Document Type: Review

References (127)

1. Al-Omran M, Albalawi ZH, Tashkandi MF, and Al-Ansary LA. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev CD002837, 2010.
2. Ammann RW and Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut 35: 552-556, 1994. (Pubitemid 24131256)
3. Andersen DK and Frey CF. The evolution of the surgical treatment of chronic pancreatitis. Ann Surg 251: 18-32, 2010.
4. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc 56: S226-S230, 2002. (Pubitemid 36236848)
5. Bertelli E and Bendayan M. Association between endocrine pancreas and ductal system. More than an epiphenomenon of endocrine differentiation and development? J Histochem Cytochem 53: 1071-1086, 2005. (Pubitemid 41262976)
6. Bertelli E, Regoli M, and Bastianini A. Endocrine tissue associated with the pancreatic ductal system: a light and electron microscopic study of the adult rat pancreas with special reference to a new endocrine arrangement. Anat Rec 239: 371-378, 1994. (Pubitemid 24225798)
7. Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, and Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol 6: 42, 2006.
8. Birck R, Keim V, Fiedler F, van der Woude FJ, and Rohmeiss P. Pancreatitis after losartan. Lancet 351: 1178, 1998. (Pubitemid 28171827)
9. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, and Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908, 2007. (Pubitemid 46707844)
10. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, and Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119: 2634-2647, 2009.
11. Bosch X. Losartan-induced acute pancreatitis. Ann Intern Med 127: 1043-1044, 1997.
12. Boveris A and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134: 707-716, 1973.
13. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644, 1992.
14. Chan YC and Leung PS. AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury. Regul Pept 134: 46-53, 2006.
15. Chan YC and Leung PS. Acute pancreatitis: animal models and recent advances in basic research. Pancreas 34: 1-14, 2007. (Pubitemid 46045717)
16. Chan YC and Leung PS. Angiotensin II type 1 receptordependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis. J Pharmacol Exp Ther 323: 10-18, 2007.
17. Chan YC and Leung PS. Involvement of redox-sensitive extracellular- regulated kinases in angiotensin II-induced interleukin-6 expression in pancreatic acinar cells. J Pharmacol Exp Ther 329: 450-458, 2009.
18. Chappell MC, Diz DI, and Gallagher PE. The reninangiotensin system and the exocrine pancreas. JOP 2: 33-39, 2001.
19. Chappell MC, Jacobsen DW, and Tallant EA. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides 16: 741-747, 1995.
20. Chen P, Yuan Y, Wang S, Zhan L, and Xu J. Captopril, an Angiotensin-converting enzyme inhibitor, attenuates the severity of acute pancreatitis in rats by reducing expression of matrix metalloproteinase 9. Tohoku J Exp Med 209: 99-107, 2006.
21. Cheung WT, Yeung SY, Yiu AK, Ip TM, Wan DC, Luk SK, and Ho WK. Characterization of a functional AT1A angiotensin receptor in pancreatoma AR4-2J cells. Peptides 20: 829-836, 1999. (Pubitemid 29378284)
22. Chipitsyna G, Gong Q, Gray CF, Haroon Y, Kamer E, and Arafat HA. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells. Endocrinology 148: 2198-2208, 2007. (Pubitemid 46997051)
23. Chu KY, Lau T, Carlsson PO, and Leung PS. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55: 367-374, 2006. (Pubitemid 43343265)
24. Chu KY and Leung PS. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal 9: 869-878, 2007. (Pubitemid 46919590)
25. Chu KY and Leung PS. Angiotensin II in type 2 diabetes mellitus. Curr Protein Pept Sci 10: 75-84, 2009.
26. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, and Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339: 653-658, 1998. (Pubitemid 28402089)
27. Czako L, Hegyi P, Rakonczay Z, Jr., Wittmann T, and Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology 9: 351-359, 2009.
28. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
29. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, and Acton S. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
30. Doughan AK, Harrison DG, and Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496, 2008. (Pubitemid 351651106)
31. Ehlers RA,Hernandez A, Bloemendal LS, Ethridge RT, Farrow B, and Evers BM. Mitochondrial DNA damage and altered membrane potential (delta psi) in pancreatic acinar cells induced by reactive oxygen species. Surgery 126: 148-155, 1999. (Pubitemid 29382774)
32. Fagenholz PJ, Fernandez-del Castillo C, Harris NS, Pelletier AJ, and Camargo CA, Jr. Direct medical costs of acute pancreatitis hospitalizations in the United States. Pancreas 35: 302-307, 2007. (Pubitemid 350307371)
33. Famularo G, Minisola G, Nicotra GC, and De Simone C. Acute pancreatitis associated with irbesartan therapy. Pancreas 31: 294-295, 2005. (Pubitemid 41400492)
34. Fisher AA and Bassett ML. Acute pancreatitis associated with angiotensin II receptor antagonists. Ann Pharmacother 36: 1883-1886, 2002. (Pubitemid 35429559)
35. Folch E, Salas A, Panes J, Gelpi E, Rosello-Catafau J, Anderson DC, Navarro S, Pique JM, Fernandez-Cruz L, and Closa D. Role of P-selectin and ICAM-1 in pancreatitisinduced lung inflammation in rats: significance of oxidative stress. Ann Surg 230: 792-798, 1999; discussion 798-799.
36. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Qt, Taylor WR, Harrison DG, de Leon H, Wilcox JN, and Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80: 45-51, 1997. (Pubitemid 27030367)
37. Gao L and Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20, 2009.
38. Garlid KD, Dos Santos P, Xie ZJ, Costa AD, and Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K( + ) channel in cardiac function and cardioprotection. Biochim Biophys Acta 1606: 1-21, 2003. (Pubitemid 37267867)
39. Garrido AM and Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158, 2009.
40. Greenstein RJ, Krakoff LR, and Felton K. Activation of the renin systemin acute pancreatitis. Am JMed 82: 401-404, 1987.
41. Gukovskaya AS, Vaquero E, Zaninovic V, Gorelick FS, Lusis AJ, Brennan ML, Holland S, and Pandol SJ. Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 122: 974-984, 2002. (Pubitemid 34267281)
42. Gupta R, Patel K, Calder PC, Yaqoob P, Primrose JN, and Johnson CD. A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II or = 6). Pancreatology 3: 406-413, 2003. (Pubitemid 37409870)
43. Gurusamy KS, Farouk M, and Tweedie JH. UK guidelines for management of acute pancreatitis: is it time to change? Gut 54: 1344-1345, 2005. (Pubitemid 41192501)
44. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, Wierzbicki K, Korbut R, Harrison DG, and Channon KM. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26: 333-339, 2006. (Pubitemid 43732196)
45. Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Koga H, and Noguchi T. Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med 35: 1471-1478, 2009.
46. Hama K, Ohnishi H, Aoki H, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Mashima H, Yasuda H, and Sugano K. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway. Biochem Biophys Res Commun 340: 742-750, 2006. (Pubitemid 43053893)
47. Hama K, Ohnishi H, Yasuda H, Ueda N, Mashima H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, and Sugano K. Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation. Biochem Biophys Res Commun 315: 905-911, 2004. (Pubitemid 38249389)
48. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, and Terzic A. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 275: H1567-H1576, 1998.
49. Hu R, Wang YL, Edderkaoui M, Lugea A, Apte MV, and Pandol SJ. Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology 7: 332-340, 2007. (Pubitemid 47482094)
50. Hucl T, Kylanpaa ML, Kunzli B, Witt H, Lempinen M, Schneider A, Kemppainen E, Lohr M, Haas SL, Friess H, Ockenga J, Rosendahl J, Schulz HU, Gress T, Singer MV, and Pfutzer RH. Angiotensin-converting enzyme insertion/deletion polymorphism in patients with acute and chronic pancreatitis. Eur J Gastroenterol Hepatol 21: 1032-1035, 2009.
51. Inukai T, Yoshida N, Wakabayashi S, Inukai Y, Matsutomo R, Takanashi K, Nakamachi T, Takebayashi K, Aso Y, and Takahashi K. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus. Am J Med Sci 329: 222-227, 2005. (Pubitemid 40695448)
52. Ip SP, Tsang SW, Wong TP, Che CT, and Leung PS. Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in ceruleininduced acute pancreatitis. Pancreas 26: 224-229, 2003. (Pubitemid 36384152)
53. Jupp J, Fine D, and Johnson CD. The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol 24: 219-231, 2010.
54. Kadowaki D, Anraku M, Tasaki Y, Kitamura K, Wakamatsu S, Tomita K, Gebicki JM, Maruyama T, and Otagiri M. Effect of olmesartan on oxidative stress in hemodialysis patients. Hypertens Res 30: 395-402, 2007. (Pubitemid 46958889)
55. Kampf C, Lau T, Olsson R, Leung PS, and Carlsson PO. Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts. Diabetologia 48: 1159-1167, 2005. (Pubitemid 40909652)
56. Keidar S, Kaplan M, and Gamliel-Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc Res 73: 463-469, 2007. (Pubitemid 46091776)
57. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, and Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 45: 438-444, 2005. (Pubitemid 40315815)
58. Kirk GR, White JS, McKie L, Stevenson M, Young I, Clements WD, and Rowlands BJ. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg 10: 499-503, 2006. (Pubitemid 43696992)
59. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, Kim MJ, Jeong IK, and Yoon KH. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 98: 343-355, 2006.
60. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T, and Itoh M. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 124: 1010-1019, 2003. (Pubitemid 36389804)
61. Labios M, Martinez M, Gabriel F, Guiral V, Ruiz-Aja S, Beltran B, and Munoz A. Effects of eprosartan on mitochondrial membrane potential and H2O2 levels in leucocytes in hypertension. J Hum Hypertens 22: 493-500, 2008. (Pubitemid 351877737)
62. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, and Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106: 3073-3078, 2002. (Pubitemid 35440291)
63. Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, and Drexler H. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27: 943-948, 2007. (Pubitemid 46606729)
64. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, andGriendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redoxsensitive signaling pathways. Circ Res 88: 888-894, 2001. (Pubitemid 32441466)
65. Lau T, Carlsson PO, and Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47: 240-248, 2004. (Pubitemid 38315360)
66. Lavigne MC, Malech HL, Holland SM, and Leto TL. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104: 79-84, 2001. (Pubitemid 32623293)
67. Leeson TS and Leeson R. Close association of centroacinar/ductular and insular cells in the rat pancreas. Histol Histopathol 1: 33-42, 1986. (Pubitemid 16088608)
68. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol Lond 580: 31-37, 2007. (Pubitemid 46470642)
69. Leung PS, Chan HC, Fu LX, and Wong PY. Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J Endocrinol 153: 269-274, 1997. (Pubitemid 27219459)
70. Leung PS, Chan WP, Wong TP, and Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 160: 13-19, 1999. (Pubitemid 29044563)
71. Leung PS and Chan YC. Role of oxidative stress in pancreatic inflammation. Antioxid Redox Signal 11: 135-165, 2009.
72. Leung PS and Chappell MC. A local pancreatic reninangiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol 35: 838-846, 2003. (Pubitemid 36379325)
73. Liu WB, Wang XP, Wu K, and Zhang RL. Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J Gastroenterol 11: 6489-6494, 2005. (Pubitemid 43136886)
74. Madro A, Korolczuk A, Czechowska G, Celinski K, Slomka M, Prozorow-Krol B, and Korobowicz E. RAS inhibitors decrease apoptosis of acinar cells and increase elimination of pancreatic stellate cells after in the course of experimental chronic pancreatitis induced by dibutyltin dichloride. J Physiol Pharmacol 59 Suppl 2: 239-249, 2008.
75. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, and Elton TS. The human angiotensin II type 1 receptor + 1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 282: 24262-24269, 2007. (Pubitemid 47328062)
76. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, and Elton TS. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 281: 18277-18284, 2006. (Pubitemid 44035484)
77. Masamune A, Watanabe T, Kikuta K, Satoh K, and Shimosegawa T. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 294: G99-G108, 2008.
78. McClave SA, Chang WK, Dhaliwal R, and Heyland DK. Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN J Parenter Enteral Nutr 30: 143-156, 2006. (Pubitemid 44314788)
79. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, and Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285: H2290-H2297, 2003. (Pubitemid 37443044)
80. McNally JS, Saxena A, Cai H, Dikalov S, and Harrison DG. Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol 25: 1623-1628, 2005. (Pubitemid 41098931)
81. Meier R, Beglinger C, Layer P, Gullo L, Keim V, Laugier R, Friess H, Schweitzer M, and Macfie J. ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr 21: 173-183, 2002.
82. Mitchell RM, Byrne MF, and Baillie J. Pancreatitis. Lancet 361: 1447-1455, 2003. (Pubitemid 36515050)
83. Moriwaki Y, Yamamoto T, and Higashino K. Distribution and pathophysiologic role of molybdenum-containing enzymes. Histol Histopathol 12: 513-524, 1997. (Pubitemid 27240323)
84. Nagashio Y, Asaumi H, Watanabe S, Nomiyama Y, Taguchi M, Tashiro M, Sugaya T, and Otsuki M. Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 287: G170-G177, 2004. (Pubitemid 38802131)
85. Ni W, Zhan Y, He H, Maynard E, Balschi JA, and Oettgen P. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ Res 101: 985-994, 2007. (Pubitemid 350084976)
86. Nonaka A, Manabe T, Tamura K, Asano N, Imanishi K, and Tobe T. Changes of xanthine oxidase, lipid peroxide and superoxide dismutase in mouse acute pancreatitis. Digestion 43: 41-46, 1989. (Pubitemid 19223050)
87. Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, and Sunagawa K. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens 26: 2176-2184, 2008.
88. Oruc N, Lamb J, Kutlu OC, Barmada MM, Money ME, Slivka A, and Whitcomb DC. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis. JOP 5: 457-463, 2004. (Pubitemid 41573848)
89. Oruc N, Ozutemiz O, Nart D, Yuce G, Celik HA, and Ilter T. Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target? Exp Toxicol Pathol 62: 353-360, 2010.
90. Oruc N, Papachristou GI, Avula H, Slivka A, Lamb J, and Whitcomb DC. Angiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severity. HPB (Oxford) 11: 45-49, 2009.
91. Park IS and Bendayan M. Endocrine cells in the rat pancreatic and bile duct system: alteration in diabetes. Pancreas 9: 566-573, 1994. (Pubitemid 24276946)
92. Pereda J, Sabater L, Cassinello N, Gomez-Cambronero L, Closa D, Folch-Puy E, Aparisi L, Calvete J, Cerda M, Lledo S, Vina J, and Sastre J. Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann Surg 240: 108-116, 2004. (Pubitemid 38808242)
93. Rahman SH, Ibrahim K, Larvin M, Kingsnorth A, and McMahon MJ. Association of antioxidant enzyme gene polymorphisms and glutathione status with severe acute pancreatitis. Gastroenterology 126: 1312-1322, 2004. (Pubitemid 38552796)
94. Rahman SH, Nanny C, Ibrahim K, O'Reilly D, Larvin M, Kingsnorth AJ, andMcMahonMJ. Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity.DigDis Sci 50: 1376-1383, 2005. (Pubitemid 41184772)
95. Raizada MK and Ferreira AJ. ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol 50: 112-119, 2007. (Pubitemid 47267736)
96. Reinehr R, Zoller S, Klonowski-Stumpe H, Kordes C, and Haussinger D. Effects of angiotensin II on rat pancreatic stellate cells. Pancreas 28: 129-137, 2004. (Pubitemid 38269772)
97. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990. (Pubitemid 20370444)
98. Sekimoto M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Hirota M, Kimura Y, Takeda K, Isaji S, Koizumi M, Otsuki M, and Matsuno S. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 13: 10-24, 2006. (Pubitemid 43193670)
99. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002. (Pubitemid 35034208)
100. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, and Antonarakis SE. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81: 405-413, 2007. (Pubitemid 47236088)
101. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, and Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339: 645-652, 1998. (Pubitemid 28402088)
102. Shen L, Mo H, Cai L, Kong T, Zheng W, Ye J, Qi J, and Xiao Z. Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogenactivated protein kinases. Shock 31: 500-506, 2009.
103. Shilo S, Roy S, Khanna S, and Sen CK. MicroRNA in cutaneous wound healing: a new paradigm. DNA Cell Biol 26: 227-237, 2007. (Pubitemid 46776607)
104. Singh L, Bakshi DK,Majumdar S,Arora SK, Vasishta RK, and Wig JD. Mitochondrial dysfunction and apoptosis of acinar cells in chronic pancreatitis. J Gastroenterol 43: 473-483, 2008. (Pubitemid 351997885)
105. Sjoberg Bexelius T, Garcia Rodriguez LA, and Lindblad M. Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology 9: 786-792, 2009.
106. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, and Hahn SA. MicroRNA expression alterations are linked to tumorigenesis and nonneoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26: 4442-4452, 2007. (Pubitemid 47014466)
107. Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, Imrie C, and Tandon R. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 17 Suppl: S15-S39, 2002. (Pubitemid 34539295)
108. Touyz RM, Yao G, Quinn MT, Pagano PJ, and Schiffrin EL. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 25: 512-518, 2005. (Pubitemid 40315671)
109. Touyz RM, Yao G, and Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 981-987, 2003. (Pubitemid 36717143)
110. Tsang SW, Cheng CH, and Leung PS. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 119: 213-219, 2004. (Pubitemid 38553840)
111. Tsang SW, Ip SP, and Leung PS. Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 36: 330-339, 2004. (Pubitemid 37487767)
112. Tsang SW, Ip SP, Wong TP, Che CT, and Leung PS. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 111: 47-53, 2003. (Pubitemid 36254748)
113. Tsirambidis JV, Conwell DL, and Zuccaro G. Chronic pancreatitis. MedGenMed 5: 17, 2003.
114. Turrens JF and Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191: 421-427, 1980.
115. Ulmasov B, Xu Z, Tetri LH, Inagami T, and Neuschwander-Tetri BA. Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 296: G284-G294, 2009.
116. van Acker GJ, Perides G, and Steer ML. Co-localization hypothesis: a mechanism for the intrapancreatic activation of digestive enzymes during the early phases of acute pancreatitis. World J Gastroenterol 12: 1985-1990, 2006.
117. Waldeck K, Lindberg BF, Persson K, and Andersson KE. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study. Br J Pharmacol 121: 1081-1086, 1997. (Pubitemid 27303575)
118. Waud WR and Rajagopalan KV. The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O). Arch Biochem Biophys 172: 365-379, 1976.
119. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK, Jr., Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, and Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14: 141-145, 1996. (Pubitemid 26338792)
120. Wingler K,Wunsch S, Kreutz R, Rothermund L, Paul M, and Schmidt HH. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31: 1456-1464, 2001. (Pubitemid 33145316)
121. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, and Becker M. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25: 213-216, 2000. (Pubitemid 30394996)
122. Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, Ando T, Sano H, Nakazawa T, Ohara H, Nomura T, Joh T, and Itoh M. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 307: 17-23, 2003. (Pubitemid 37151887)
123. Yamada T, Kuno A, Ogawa K, Tang M, Masuda K, Nakamura S, Ando T, Okamoto T, Ohara H, Nomura T, Joh T, Shirai T, and Itoh M. Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. J Pharmacol Exp Ther 313: 36-45, 2005. (Pubitemid 40411325)
124. Yu JH, Lim JW, Kim H, and Kim KH. NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells. Int J Biochem Cell Biol 37: 1458-1469, 2005.
125. Zeki S, Miura S, Suzuki H, Watanabe N, Adachi M, Yokoyama H, Horie Y, Saito H, Kato S, and Ishii H. Xanthine oxidase-derived oxygen radicals play significant roles in the development of chronic pancreatitis in WBN/Kob rats. J Gastroenterol Hepatol 17: 606-616, 2002. (Pubitemid 34748184)
126. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, and Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res 89: 1177-1183, 2001. (Pubitemid 34627876)
127. Zhang GX, Lu XM, Kimura S, and Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 76: 204-212, 2007. (Pubitemid 350198600)